Proton & Multinuclear Spectroscopy of Muscle
Linda Heskamp1
1Newcastle University, United Kingdom

Synopsis

This lecture introduces the basic principles of MR Spectroscopy at a basic level suitable for clinicians with a specific focus on skeletal muscle. Metabolites detectable with 1H MRS, 31P MRS, 13C MRS and 23NA MRS will be discussed together with the software and hardware requirements.

Magnetic resonance spectroscopy (MRS) is a non-invasive technique that is able to measure the concentrations of different chemical components in tissue; it can be used to measure tissue metabolism.

An MR spectrum shows peaks at different frequencies, because each metabolite has a slightly different resonance frequency. This difference in resonance frequency is the result of the electron shielding effect. Electrons rotate around the nucleus and produce their own small local magnetic field (Bind) in the presence of the main magnetic field (B0). The effective magnetic field (Beffective) experienced by the nucleus is B0 minus Bind. The electron shielding effect depends on the molecular structure of a metabolite and therefore each metabolite experiences a slightly different Beffective. The resonance frequency of metabolite is then determined by the Larmor equation ($$$\omega_{0}=\gamma B_{effective}$$$).

The resonance frequency and shielding effect are field dependent, which makes it difficult to compare spectra between different field strength. This issue is overcome by using the chemical shift instead of the resonance frequency. Chemical shift is the difference in resonance frequency of a metabolite relative to a reference compound and expressed in parts per million. For 1H MRS, the chosen reference compound tetramethylsilane (TMS) and consequently water will always resonate at 4.7 ppm, independent of field strength.

This lecture will also discuss the following factors that affect the size and shape of peak in the MR spectrum:
1) Concentration of a nucleus in the measured sample determines the height of the peak
2) T1 and T2 relaxation times of the metabolite in combination with the chosen repetition time (TR) and echo time (TE). The TR and TE affect the height of the peak via the T1 and T2 relaxation times of the metabolite. Furthermore, the T2 relaxation time also affects the linewidth of a peak, longer T2 relaxation times give narrower peaks.
3) Magnetic inhomogeneity will reduce the T2* and lead to a broadening of the peaks in a spectrum. To minimize this effect shimming is critical.
4) Presence of hidden/underlying peaks can alter the shape of a peak.
5) Processed like J-coupling can make the peak appear as multiplet instead of a singlet.

Further focus of this lecture will be on an overview of the detectable metabolites per nucleus (1H, 31P, 13C and 23NA).This will include the recently published consensus papers on how to reliably measure metabolites detectable with 1H MRS and 31P MRS. Metabolites to be discussed will for example be intramyocellular lipids, carnosine, acetylcarnitine, phosphocreatine, inorganic phosphate and ATP.

Acknowledgements

No acknowledgement found.

References

Krssak et al. Proton magnetic resonance spectroscopy in skeletal muscle:Experts' consensus recommendations. NMR Biomed 2019. DOI: 10.1002/nbm.4266

Meyerspeer et al. 31P magnetic resonance spectroscopy in skeletal muscle:Experts' consensus recommendations. NMR Biomed 2019 DOI: 10.1002/nbm.4246

Popadic et al. Intramyocellular lipids and their dynamics assessed by 1Hmagnetic resonance spectroscopy. Clin Physiol Func Imaging 2017. doi: 10.1111/cpf.12346558

Valkovic et al. Multinuclear Magnetic Resonance Spectroscopy of Human Skeletal Muscle Metabolism in Training and Disease. http://dx.doi.org/10.5772/intechopen.77107

Kreis et al. Terminology and concepts for the characterization of in vivoMR spectroscopy methods and MR spectra: Background andexperts' consensus recommendations. NMR Biomed 2020. DOI: 10.1002/nbm.4347

Proc. Intl. Soc. Mag. Reson. Med. 30 (2022)